Keybanc Maintains Overweight on Hinge Health, Raises Price Target to $140

Keybanc analyst Scott Schoenhaus has maintained an Overweight rating on Hinge Health (NYSE: HNGE) and raised the price target from $125 to $140. This adjustment reflects a positive outlook for the company's performance in the market.